PL2897608T3 - Leczenie choroby Alzheimera i zaburzeń poznawczych za pomocą andrografolidów - Google Patents

Leczenie choroby Alzheimera i zaburzeń poznawczych za pomocą andrografolidów

Info

Publication number
PL2897608T3
PL2897608T3 PL14787478T PL14787478T PL2897608T3 PL 2897608 T3 PL2897608 T3 PL 2897608T3 PL 14787478 T PL14787478 T PL 14787478T PL 14787478 T PL14787478 T PL 14787478T PL 2897608 T3 PL2897608 T3 PL 2897608T3
Authority
PL
Poland
Prior art keywords
andrographolides
alzheimer
treatment
cognitive impairment
cognitive
Prior art date
Application number
PL14787478T
Other languages
English (en)
Inventor
Nibaldo C. INESTROSA
Juan L. HANKCKE OROZCO
Original Assignee
Innobioscience, Llc
Nibaldo C. INESTROSA
HANCKE OROZCO, Juan, L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innobioscience, Llc, Nibaldo C. INESTROSA, HANCKE OROZCO, Juan, L. filed Critical Innobioscience, Llc
Publication of PL2897608T3 publication Critical patent/PL2897608T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14787478T 2013-04-22 2014-04-21 Leczenie choroby Alzheimera i zaburzeń poznawczych za pomocą andrografolidów PL2897608T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361814445P 2013-04-22 2013-04-22
PCT/US2014/034758 WO2014176149A1 (en) 2013-04-22 2014-04-21 Treatment of alzheimer's and cognitive impairment with andrographolides
EP14787478.8A EP2897608B1 (en) 2013-04-22 2014-04-21 Treatment of alzheimer's and cognitive impairment with andrographolides

Publications (1)

Publication Number Publication Date
PL2897608T3 true PL2897608T3 (pl) 2019-07-31

Family

ID=51792315

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14787478T PL2897608T3 (pl) 2013-04-22 2014-04-21 Leczenie choroby Alzheimera i zaburzeń poznawczych za pomocą andrografolidów

Country Status (5)

Country Link
US (1) US20150352075A1 (pl)
EP (1) EP2897608B1 (pl)
ES (1) ES2702619T3 (pl)
PL (1) PL2897608T3 (pl)
WO (1) WO2014176149A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104861010B (zh) * 2014-11-27 2016-06-29 江西省药品检验检测研究院 一种新的劳丹烷型二萜苷化合物及其制备方法和用途
MY176459A (en) * 2016-05-23 2020-08-10 Univ Putra Malaysia Extract of andrographis paniculata for cognitive enhancement
CN109824655B (zh) * 2019-04-08 2021-09-24 沈阳药科大学 穿心莲内酯化合物及其制备方法和用途
US20220409573A1 (en) * 2021-06-11 2022-12-29 Innobioscience, Llc Hippocampus Regeneration And Memory Recovery
AU2024271399A1 (en) * 2023-05-18 2025-12-18 Enveda Therapeutics, Inc. Isoandrographolide analogs and method for treatment using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2699901A (en) * 2000-01-13 2001-07-24 Serono Genetics Institute S.A. Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders
MXPA06008738A (es) * 2004-02-03 2008-03-07 Univ Austral De Chile Composicion que comprende una mezcla de lavadnos diterpenicos, de un extracto de planta andrographis paniculata, seleccionado de andrografolido, 14-deoxiandrografolido y neoandrografolido; sus usos.
CN1666985A (zh) * 2004-03-11 2005-09-14 和记黄埔医药企业有限公司 穿心莲内酯及其衍生物、类似物的医药用途
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US7601854B2 (en) * 2006-10-25 2009-10-13 Kang Jian Biotech Corp., Ltd. Diterpenes from the fruiting body of Antrodia camphorata and pharmaceutical compositions thereof
CN101371832B (zh) * 2007-08-20 2012-05-09 烟台靶点药物研究有限公司 三乙酰穿心莲内酯作为炎性细胞因子抑制剂的医药用途
IT1397386B1 (it) * 2010-01-12 2013-01-10 Indena Spa Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso.
CN103224492B (zh) * 2013-04-15 2016-01-13 南京工业大学 14-芳基醚穿心莲內酯衍生物及其制备方法和应用

Also Published As

Publication number Publication date
ES2702619T3 (es) 2019-03-04
US20150352075A1 (en) 2015-12-10
WO2014176149A4 (en) 2014-12-04
EP2897608B1 (en) 2018-08-22
EP2897608A1 (en) 2015-07-29
EP2897608A4 (en) 2016-04-13
HK1212897A1 (en) 2016-06-24
WO2014176149A1 (en) 2014-10-30

Similar Documents

Publication Publication Date Title
IL273688A (en) Evaluation and treatment of bradykinin-mediated disorders
IL254030B (en) Use of pyridofidine to improve cognitive function and to treat Alzheimer's disease
EP2983657A4 (en) TREATMENT OF GASTROINTESTINAL AND OTHER DISEASES
GB201320723D0 (en) Composition and methods of treatment
IL240213A (en) Sulfamoyl-arylamides and their use as anti-jaundice drugs b
HUE039560T2 (hu) Mikro méretû zárófedés és kapcsolódó eljárások bõr kezelésére
IL239368A0 (en) Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system
IL237173B (en) Methods for treating hepatitis b and hepatitis d infections
IL284969A (en) Diagnosis and treatment of autoimmune diseases
IL238481A0 (en) Cancer treatment using synthetic lethal approaches
EP2968309A4 (en) USE OF LEVOCETRIXIN AND MONTELUKAST IN THE TREATMENT OF VASCULARITY
EP2867239A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES
PL2968478T3 (pl) Kompozycje i sposoby do leczenia karboksyhemoglobinemii
HUE041336T2 (hu) Petoxamid és pikloram kombinációja
SG11201601263WA (en) Recombinant microorganisms and methods of use thereof
GB201410954D0 (en) Skin treatment devices and methods
ZA201503834B (en) Identifying subjects in need of treatment
GB201309498D0 (en) Novel diagnosis and therapy
SG11201505909WA (en) Treatment and prevention of acne
IL246078A0 (en) Treatment of multiple sclerosis by a combination of laquinimod and triflunomide
GB201301685D0 (en) Diagnosis and treatment of cancer
GB201310101D0 (en) Treatment of freidreich's ataxia
GB201302646D0 (en) Therapeutic uses of flavin-containing monooxygenase 3
GB201306413D0 (en) The local treatment of ophthalmic diseases
GB201317373D0 (en) Treatment and prevention of cancer